<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Congenital Ectropion Uveae - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjYaGOq7JQLtpI71Nb3gAAAAc","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Congenital_Ectropion_Uveae","wgTitle":"Congenital Ectropion Uveae","wgCurRevisionId":89519,"wgRevisionId":89519,"wgArticleId":10073,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Congenital_Ectropion_Uveae","wgRelevantArticleId":10073,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],
"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Congenital ectropion uveae (CEU) (i.e. congenital iris ectropion syndrome, primary iris pigment epithelial hyperplasia) is a rare disorder with unilateral anterior chamber dysgenesis that commonly leads to unilateral secondary glaucoma in the mid-teenage years with associated morbidity and possible blindness. It is characterized by ectropion uveae that is present since birth and subsequent glaucoma due to trabecular meshwork and Schlemm’s canal dysgenesis."/>
<meta name="date" content="2023-02-08"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Congenital Ectropion Uveae" href="/w/index.php?title=Special:ExportRDF/Congenital_Ectropion_Uveae&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Congenital_Ectropion_Uveae rootpage-Congenital_Ectropion_Uveae layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Congenital+Ectropion+Uveae" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Congenital+Ectropion+Uveae" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzz0hc07"></button>
					<div class="collapse navbar-collapse hbpzz0hc07" id="hbpzz0hc07">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Congenital_Ectropion_Uveae" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Congenital_Ectropion_Uveae&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Congenital_Ectropion_Uveae#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Congenital Ectropion Uveae</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Eric.williams" title="User:Eric.williams">Eric Williams, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>,&#160;<a href="/User:Koushik.Tripathy" title="User:Koushik.Tripathy">Koushik Tripathy, MD (AIIMS), FRCS (Glasgow)</a>,&#160;<a href="/User:Eric.williams" title="User:Eric.williams">Eric Williams, MD</a>,&#160;<a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a> on February 9, 2023.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div class="infobox vertical">
<div class="info-section vertical" style="margin-bottom: 10px;">
<div class="info-section-header">Congenital Ectropion Uveae
  </div>
<div class="info-section-body">
  </div>
</div>
<div class="info-section vertical" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/File:CEU_Intro.jpg" class="image"><img alt="External photo demonstrating ectropion uveae and corectopia" src="/w/images/1/d/db/CEU_Intro.jpg" decoding="async" width="264" height="195" /></a> 
     </div>
<div class="info-section-body"><b>Figure 1:</b>. External photo demonstrating ectropion uveae and corectopia in a 7-year-old patient with congenital ectropion uveae. Photo courtesy of Leonard Seibold, MD.     
     </div>
</div>
<div class="info-section horizontal" style="margin-bottom: 10px;">
<div class="info-section-header"><a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems">ICD</a>-<a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/ICD-10">10</a>
        </div>
<div class="info-section-body"><a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/ICD-10_Chapter_VII:_Diseases_of_the_eye,_adnexa">H</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/H21.8">21.8</a> <a rel="nofollow" class="external autonumber" href="http://en.wikipedia.org/wiki/ICD-10_Chapter_Q">[1]</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/Q15.0">15.0</a>
        </div>
</div>
</div>
<p>Congenital ectropion uveae (CEU) (i.e. congenital iris ectropion syndrome, primary iris pigment epithelial hyperplasia) is a rare disorder with unilateral anterior chamber dysgenesis that commonly leads to unilateral secondary glaucoma in the mid-teenage years with associated morbidity and possible blindness. It is characterized by ectropion uveae that is present since birth and subsequent glaucoma due to trabecular meshwork and Schlemm’s canal dysgenesis. 
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Background"><span class="tocnumber">1</span> <span class="toctext">Background</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Disease_Entity"><span class="tocnumber">2</span> <span class="toctext">Disease Entity</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Etiology"><span class="tocnumber">2.1</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Risk_Factors"><span class="tocnumber">2.2</span> <span class="toctext">Risk Factors</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Pathophysiology"><span class="tocnumber">2.3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Ectropion_Uveae_and_Neurofibromatosis_type_1"><span class="tocnumber">2.4</span> <span class="toctext">Ectropion Uveae and Neurofibromatosis type 1</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#History"><span class="tocnumber">3.1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Clinical_diagnosis"><span class="tocnumber">3.2</span> <span class="toctext">Clinical diagnosis</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Diagnostic_procedures"><span class="tocnumber">3.3</span> <span class="toctext">Diagnostic procedures</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Differential_diagnosis"><span class="tocnumber">3.4</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Management"><span class="tocnumber">4</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-13"><a href="#Medical_therapy"><span class="tocnumber">4.1</span> <span class="toctext">Medical therapy</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Surgery"><span class="tocnumber">4.2</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Prognosis"><span class="tocnumber">4.3</span> <span class="toctext">Prognosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Background">Background</span></h1>
<p>The term congenital ectropion was first introduced by Colsman in 1869<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup>, but it was later discovered that his description was actually iris flocculi. The first authors to accurately describe congenital ectropion were Wicherkiewicz in 1891<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup> and Spiro in 1896<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup>.
</p>
<h1><span class="mw-headline" id="Disease_Entity">Disease Entity</span></h1>
<p>Congenital ectropion uveae (CEU) does not have a specific code as per the International Classification of Diseases (ICD) nomenclature. We recommend the following codes as appropriate.
</p><p>H21.89 Other specified disorders of iris and ciliary body
</p><p>Q15.0 Congenital glaucoma
</p>
<h2><span class="mw-headline" id="Etiology">Etiology</span></h2>
<p>Ectropion uveae can be divided into two main categories: acquired and congenital. The differences are based primarily on the etiology of the ectropion. Acquired ectropion is more common than congenital, and is associated with tractional forces secondary to a fibrovascular membrane spreading across the anterior surface of the iris.  As this membrane contracts, the posterior pigmented iris epithelium is pulled around to the anterior iris surface. This fibrovascular membrane (or neovascularization of the iris) can be from multiple sources with the most common etiologies being proliferative diabetic retinopathy and central retinal vein occlusion, or less commonly inflammatory, neoplastic, or ischemic processes involving the iris. On the other hand, congenital ectropion, is thought to be the result of failure of regression of a primordial endothelium in the anterior chamber. Congenital ectropion is often nonprogressive whereas acquired will usually progress unless the underlying process is adequately treated.
</p>
<h2><span class="mw-headline" id="Risk_Factors">Risk Factors</span></h2>
<p>CEU does not have a specific genetic inheritance, and most commonly is not related to a systemic condition. However, NF-1 and other less common syndromes (facial hemihypertrophy, Prader-Willi syndrome) have been reported to have an association with CEU (see below)<sup id="cite_ref-:0_4-0" class="reference"><a href="#cite_note-:0-4">&#91;4&#93;</a></sup>.
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span></h2>
<p>CEU is thought to be caused by reactive hyperplasia of the iris pigment epithelium. This hyperplasia is incited by failure of regression of the primordial endothelium that lines the anterior chamber. It is thought that the failure of regression is secondary to developmental arrest of neural crest tissue in utero. This also leads to anterior iris insertion and angle dysgenesis. The trigger for arrest of migration has not been identified to this date. Some authors postulate that it may be related to a primary vascular insult that leads to defective neural crest cell migration. Harasymowycz PJ et al. presented a case of CEU, which on histopathologic examination was found to have a fibrovascular membrane in the anterior iris stroma<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup>. This brings up the possibility that a vascular insult could be the cause of the defect in neural crest migration. Such arrest of neural crest migration has been demonstrated to occur due to a vascular insult in an embryonal study of the heart in hypoxia-inducible factor-1 knockout mice<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup>.
</p>
<h2><span class="mw-headline" id="Ectropion_Uveae_and_Neurofibromatosis_type_1">Ectropion Uveae and Neurofibromatosis type 1</span></h2>
<p>Glaucoma is a known ocular complication associated with NF-1. Ectropion uveae associated with NF-1 is thought to occur secondary to endothelialization of the iris leading to tractional forces resulting in ectropion uveae. These changes along with iridocorneal adhesions may lead to glaucoma. It is known that orbital involvement of NF-1, especially a lid neurofibroma, increases the odds of developing glaucoma. Similarly, the presence of ectropion uveae is closely correlated with the risk of developing glaucoma. In a cohort of 56 NF-1 patients, 13 had glaucoma, and of these, 8 of them had ectropion uveae. Of the 43 patients without glaucoma, only four had ectropion uveae, and all four were found to have partial angle closure<sup id="cite_ref-:3_7-0" class="reference"><a href="#cite_note-:3-7">&#91;7&#93;</a></sup>. Unfortunately, visual prognosis of patients with glaucoma and NF-1 is poor. In the aforementioned study by Morales et al., all of the patients that were able to give a reliable visual acuity were either legally or completely blind.<sup id="cite_ref-:3_7-1" class="reference"><a href="#cite_note-:3-7">&#91;7&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Diagnosis">Diagnosis</span></h1>
<p>CEU is largely a clinical diagnosis based on the presence of ectropion uveae and angle dysgenesis that has been present since birth with no other known underlying causes of ectropion uvea present.
</p>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>A detailed family history should be assessed to evaluate for any possible related systemic syndromes such as NF-1. A history of anisocoria may be elucidated that is often noted in infancy or early childhood.  Careful review of old photographs can reveal the longstanding nature of subtle anisocoria.  Given the later onset of glaucoma, the classic triad of epiphora, photophobia, and blepharospasm associated with congenital glaucoma is often not present.  Some patients may present with late symptoms of secondary glaucoma or elevated intraocular pressure such as headaches, blurred vision, or eye pain.  
</p>
<h2><span class="mw-headline" id="Clinical_diagnosis">Clinical diagnosis</span></h2>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:602px;"><a href="/File:CEU_Signs_copy.jpg" class="image"><img alt="" src="/w/images/1/thumb/d/d9/CEU_Signs_copy.jpg/600px-CEU_Signs_copy.jpg" decoding="async" width="600" height="198" class="thumbimage" srcset="/w/images/1/thumb/d/d9/CEU_Signs_copy.jpg/900px-CEU_Signs_copy.jpg 1.5x, /w/images/1/d/d9/CEU_Signs_copy.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:CEU_Signs_copy.jpg" class="internal" title="Enlarge"></a></div><b>Figure 2</b>: External photographs of both eyes in a patient with CEU demonstrating anisocoria.&#160; The right eye (left photo) demonstrates corectopia, ectropion uveae, and a smooth, cryptless iris surface. The normal left eye (right photo) is included for comparison. Photos courtesy of Leonard Seibold, MD.</div></div></div></div>
<p>CEU most commonly presents unilaterally (although bilateral cases have been described)<sup id="cite_ref-:0_4-1" class="reference"><a href="#cite_note-:0-4">&#91;4&#93;</a></sup>. Typical clinical findings include a glassy, smooth, cryptless iris surface, iris stromal atrophy, proliferation of iris pigment epithelium onto the anterior surface of the iris, and glaucoma. The pupil is typically round and reactive to light but may grossly appear irregular because of the abnormal iris pigment epithelium. In addition, mild ptosis may be noted in the affected eye with normal levator function. This is likely related to the neural crest origin of Müller's muscle. Gonioscopic findings of CEU most often include an anterior iris insertion, which can extend almost to Schwalbe’s line (but there should be no PAS or peripheral anterior synechia or other pathology that extends past). Secondary glaucoma is a very common complication of CEU, although it tends to occur at a later age, often diagnosed in late childhood or early adolescence. The range of diagnosis of glaucoma was from 7 months to 42 years in two case reports by Ritch R et al., and Dowling JL Jr., et al<sup id="cite_ref-:0_4-2" class="reference"><a href="#cite_note-:0-4">&#91;4&#93;</a></sup><sup id="cite_ref-:1_8-0" class="reference"><a href="#cite_note-:1-8">&#91;8&#93;</a></sup>. Clinical findings usually demonstrate an enlarged cup-to-disc ratio in the affected eye, with significant asymmetry compared to the unaffected eye. Most often, this is related to a significant increase of intraocular pressure (IOP) in the affected eye. On gonioscopy, there is a high or anterior iris insertion, which has been reported to extend almost to Schwalbe’s line<sup id="cite_ref-:0_4-3" class="reference"><a href="#cite_note-:0-4">&#91;4&#93;</a></sup><sup id="cite_ref-:1_8-1" class="reference"><a href="#cite_note-:1-8">&#91;8&#93;</a></sup>.
</p>
<h2><span class="mw-headline" id="Diagnostic_procedures">Diagnostic procedures</span></h2>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:302px;"><a href="/File:CEU_fundus.jpg" class="image"><img alt="" src="/w/images/1/thumb/1/19/CEU_fundus.jpg/300px-CEU_fundus.jpg" decoding="async" width="300" height="141" class="thumbimage" srcset="/w/images/1/thumb/1/19/CEU_fundus.jpg/450px-CEU_fundus.jpg 1.5x, /w/images/1/1/19/CEU_fundus.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:CEU_fundus.jpg" class="internal" title="Enlarge"></a></div><b>Figure 3</b>: Fundoscopic photos demonstrating significant cup-to-disc asymmetry with severe optic disc cupping of the affected left eye (right photo) in a patient with CEU. Normal right eye (left photo) included for comparison. Photos courtesy of Leonard Seibold, MD.</div></div></div></div>
<p>As above, CEU is a clinical diagnosis, and relies on slit lamp biomicroscopy to detect the characteristic abnormalities of the anterior segment as well as findings on gonioscopy. 
</p><p>The main diagnostic test for detecting glaucoma in patients with CEU is measurement of elevated IOP. Similar to congenital glaucoma, the diagnostic technique will depend on the patient’s age and ability to cooperate. In infants, an accurate IOP can be measured with a Perkins applanation tonometer or tonopen when sleeping or feeding while supine. The Icare rebound tonometer can also be used to measure an infant’s IOP. In children with CEU, if an accurate IOP cannot be obtained, a sedated exam may be required<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup>. In older, cooperative patients, standard Goldmann applanation tonometry can be performed.
</p><p>Additional diagnostic procedures to confirm the presence of glaucoma should be pursued in children with CEU. A careful optic nerve head examination with disc photos is critical to identify glaucomatous optic nerve cupping or rim thinning. Optical coherence tomography (OCT) of the optic disc can be used to assess for retinal nerve fiber layer (RNFL) thinning and Humphrey visual field (HVF) testing can evaluate for characteristic visual field loss. These tests rely on the patient’s ability to cooperate, so may not be appropriate for all patients with a diagnosis of CEU.
</p>
<h2><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span></h2>
<p><b>Iridocorneal endothelial syndrome (ICE)</b>: Similar to CEU, ICE is a unilateral condition that may result in anisocoria and corectopia. Unlike CEU, ICE commonly occurs in middle-aged adults with a preponderance of women being affected.  However one case of ICE has been reported in a child. Depending on the clinical variant of ICE, predominantly corneal (edema) or iris (polycoria, corectopia, ectropion uveae vs nodules) findings may be seen. High PAS above Schwalbe’s line is pathognomonic of ICE, and although a high anterior iris insertion is common in CEU, this would not extend above Schwalbe’s line.
</p><p><b>Axenfeld-Rieger syndrome (ARS)</b>: Similar to CEU, ARS is associated with arrest in neural crest development with resulting anterior segment abnormalities. Unlike CEU, ARS is bilateral, and associated with an autosomal dominant inheritance pattern. It can be associated with other ocular findings such as posterior embryotoxon, iris atrophy, corectopia, or polycoria. Facial abnormalities, such as maxillary hypoplasia or dental defects, may also be found in ARS as opposed to CEU.
</p><p><b>Primary congenital glaucoma (PCG)</b>: Similar to CEU, PCG would present with elevated IOP, and increased cup-to-disc ratio on exam. Unlike CEU, PCG is typically bilateral (can be asymmetric) and commonly presents soon after birth with the classical triad of epiphora, photophobia, and blepharospasm. Corneal edema and buphthalmos are also common findings of PCG not commonly seen in CEU. 
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<p>There is no known treatment for CEU. Treatment for patients with CEU is focused on treating the secondary glaucoma that is so frequently associated. 
</p><p>The treatment of glaucoma in patients with CEU usually requires surgery, although medical therapy may be initiated until more definitive treatment can be pursued.
</p>
<h2><span class="mw-headline" id="Medical_therapy">Medical therapy</span></h2>
<p>Topical IOP lowering medications that are appropriate in children include beta-blockers, carbonic anhydrase inhibitors (CAIs), and prostaglandin analogues. Alpha-2 agonists are effective in reducing IOP however, brimonidine is contraindicated in children younger than two due to respiratory and central nervous system depression.  These agents should therefore be avoided until the approximate age of 8 years old. Apraclonidine can be useful for short-term IOP reduction, but it has a high incidence of tachyphylaxis and allergy in young children. Although less likely, Apraclonidine can also produce somnolence and respiratory depression in infants and young children.
</p>
<h2><span class="mw-headline" id="Surgery">Surgery</span></h2>
<p>Glaucoma in children with CEU largely requires surgical management, similar to PCG. However, the choice of surgery is different than PCG due to severe angle dysgenesis in CEU. As a result, goniotomy in CEU has a much lower success rate than in PCG<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup><sup id="cite_ref-:2_11-0" class="reference"><a href="#cite_note-:2-11">&#91;11&#93;</a></sup>. In most cases, glaucoma filtration surgery with or without antimetabolites is the treatment of choice to control IOP<sup id="cite_ref-:2_11-1" class="reference"><a href="#cite_note-:2-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup>.
</p><p>In a case series of goniotomy in CEU by Dowling et al., three patients received six goniotomies, and even with adjunctive medication, the IOP was not adequately controlled<sup id="cite_ref-:1_8-2" class="reference"><a href="#cite_note-:1-8">&#91;8&#93;</a></sup>. In the same case report, seven of nine patients required trabeculectomy. 
</p><p>Due to the rare nature of this disorder, there is no follow-up data on treatment success rates in CEU-associated glaucoma. However, we would expect these results to be similar for other secondary pediatric glaucomas. In those cases, trabeculectomy alone has a 30 to 35 percent success rate over long-term follow-up. With adjunctive mitomycin C (MMC), the procedural success rate increases to 52 to 95 percent, with a 60 percent success rate at two years.
</p><p>Glaucoma drainage devices have a similar success rate as trabeculectomy with MMC: 44 to 95 percent success rate with 60 to 65 percent success at two years. However, adjunctive medical therapy is often necessary to maintain IOP control. In refractory cases, cyclodestructive procedures may become necessary, but these procedures may have limited success and a high complication rate<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup>.
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span></h2>
<p>Visual morbidity in CEU is closely related to the severity of glaucoma. Thus, visual prognosis is largely dependent on early diagnosis and treatment of the patient’s elevated IOP. There is no relationship that has been found between the severity of ectropion uveae and angle dysgenesis/glaucoma<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup>. Neonatal-onset congenital ectropion uveae is characterized by bilateral severe glaucoma at birth that may be resistant to treatments incluiding surgery.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup><sup id="cite_ref-:4_16-0" class="reference"><a href="#cite_note-:4-16">&#91;16&#93;</a></sup> The corneal clarity and outcomes are worse than primary congenital glaucoma. Multiple mutations in CYP1B1 have been described in this disease.<sup id="cite_ref-:4_16-1" class="reference"><a href="#cite_note-:4-16">&#91;16&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><a href="#cite_ref-1">↑</a></span> <span class="reference-text">Colsman. Papilloma Iridis (physiologische thiera ̈hnilche Bildung der Iris). Klin Monatsbl Augenheilkd. 1889:7-53.</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Wicherkiewicz B. Contribution to the knowledge of the Ectropion Uveae congenitum. Graefe's Arhiv for Ophthalmology 1891; 37: 204-07. (Translated from German to English).</span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><a href="#cite_ref-3">↑</a></span> <span class="reference-text">Spiro G. Ein Fall von Ectropion uveae congenitum. Centralbl Prakt Augenheilkd. 1896; 20:310-311.</span>
</li>
<li id="cite_note-:0-4"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_4-0">4.0</a></sup> <sup><a href="#cite_ref-:0_4-1">4.1</a></sup> <sup><a href="#cite_ref-:0_4-2">4.2</a></sup> <sup><a href="#cite_ref-:0_4-3">4.3</a></sup></span> <span class="reference-text">Ritch R, Forbes M, Hetherington J Jr, Harrison R, Podos SM. Congenital ectropion uveae with glaucoma. Ophthalmology. 1984;91:326-31.</span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><a href="#cite_ref-5">↑</a></span> <span class="reference-text">Harasymowycz PJ, Papamatheakis DG, Eagle RC, Wilson RP. Congenital ectropion uveae and glaucoma. Arch Ophthalmol 2006; 124:271-3.</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><a href="#cite_ref-6">↑</a></span> <span class="reference-text">Compernolle V, Brusselmans K, Franco D, etal. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res. 2003;60:569-579.</span>
</li>
<li id="cite_note-:3-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_7-0">7.0</a></sup> <sup><a href="#cite_ref-:3_7-1">7.1</a></sup></span> <span class="reference-text">Morales J, Chaudhry IA, Bosley TM. Glaucoma and globe enlargement associated with neurofibromatosis type 1. Ophthalmology. 2009;116(9):1725-30.</span>
</li>
<li id="cite_note-:1-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_8-0">8.0</a></sup> <sup><a href="#cite_ref-:1_8-1">8.1</a></sup> <sup><a href="#cite_ref-:1_8-2">8.2</a></sup></span> <span class="reference-text">Dowling JL Jr, Albert DM, Nelson LB, Walton DS. Primary glaucoma associated with iridotrabecular dysgenesis and ectropion uveae. Ophthalmology. 1985;92:912-21.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Pediatric Ophthalmology and Strabismus. Basic and Clinical Science Course (BCSC). American Academy of Ophthalmology, 2016-2017; pp12.</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><a href="#cite_ref-10">↑</a></span> <span class="reference-text">Mandal AK. Late onset unilateral primary developmental glaucoma associated with iridotrabecular dysgenesis, congenital ectropion uveae and thickened corneal nerves: A new neural crest syndrome? Ophthalmic Surg Lasers. 1999;30:567-70.</span>
</li>
<li id="cite_note-:2-11"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_11-0">11.0</a></sup> <sup><a href="#cite_ref-:2_11-1">11.1</a></sup></span> <span class="reference-text">Wolter JR, Butler RG. Pigment spots of the iris and ectropion uveae with glaucoma in neurofibromatosis. Am J Ophthalmol. 1963;56:964-73.</span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><a href="#cite_ref-12">↑</a></span> <span class="reference-text">Roth H, Shaffer RN. Neurofibromatosis and glaucoma. In: Bellows JG, ed. Contemporary Ophthalmology: Honoring Sir Stewart Duke- Elder. Baltimore, Md: Williams and Wilkins; 1972:180-189.</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><a href="#cite_ref-13">↑</a></span> <span class="reference-text">Beck AD. Diagnosis and management of pediatric glaucoma. Ophthalmol Clin North Am. 2001;14(3):501-512.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Wilson ME.&#160;<em>J Pediatr Ophthalmol Strabismus</em>. 1990;27(1):48-55.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Kaushik S, Dhingra D, Vibha B, Saini A, Gupta G, Snehi S, Singh N, Thattaruthody F, Pandav SS. Neonatal-Onset Congenital Ectropion Uveae: A Distinct Phenotype of Newborn Glaucoma. Am J Ophthalmol. 2021 Mar;223:83-90. doi: 10.1016/j.ajo.2020.10.001. Epub 2020 Oct 9. PMID: 33045217.</span>
</li>
<li id="cite_note-:4-16"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_16-0">16.0</a></sup> <sup><a href="#cite_ref-:4_16-1">16.1</a></sup></span> <span class="reference-text">Kaushik S, Choudhary S, Kaur A, Srivastava P, Pokharel B, Akella M, Pandav SS. Neonatal-onset Congenital Ectropion Uveae may be caused by a distinct CYP1B1 pathological variant. Am J Ophthalmol. 2022 Jan 24:S0002-9394(22)00015-0. doi: 10.1016/j.ajo.2022.01.014. Epub ahead of print. PMID: 35085548.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035202
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0 seconds
CPU time usage: 0.179 seconds
Real time usage: 0.467 seconds
Preprocessor visited node count: 862/1000000
Post‐expand include size: 10901/2097152 bytes
Template argument size: 2931/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 2123/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  281.337      1 -total
 87.07%  244.951      1 Template:Article
 73.28%  206.151      7 Template:Infobox_section
 27.62%   77.711      8 Template:UserLookup
 12.90%   36.299      1 Template:Infobox_disease
  3.96%   11.132      1 Template:Review_expired
  3.45%    9.707      1 Template:Get_active_contest
  1.06%    2.990      2 Template:ICD10
  1.05%    2.960      2 Template:Infobox_begin
  0.68%    1.901      2 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Congenital_Ectropion_Uveae&amp;oldid=89519">https://eyewiki.org/w/index.php?title=Congenital_Ectropion_Uveae&amp;oldid=89519</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzz0hdm2">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Congenital_Ectropion_Uveae" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Congenital_Ectropion_Uveae" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Congenital_Ectropion_Uveae&amp;oldid=89519" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Congenital_Ectropion_Uveae&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on February 8, 2023, at 12:37.</div>
					<div>This page has been accessed 27,905 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0},"limitreport":{"cputime":"0.179","walltime":"0.467","ppvisitednodes":{"value":862,"limit":1000000},"postexpandincludesize":{"value":10901,"limit":2097152},"templateargumentsize":{"value":2931,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":2123,"limit":5000000},"timingprofile":["100.00%  281.337      1 -total"," 87.07%  244.951      1 Template:Article"," 73.28%  206.151      7 Template:Infobox_section"," 27.62%   77.711      8 Template:UserLookup"," 12.90%   36.299      1 Template:Infobox_disease","  3.96%   11.132      1 Template:Review_expired","  3.45%    9.707      1 Template:Get_active_contest","  1.06%    2.990      2 Template:ICD10","  1.05%    2.960      2 Template:Infobox_begin","  0.68%    1.901      2 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035202","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":1248});});</script></body>
</html>